Silibinin is widely used in the pharmaceutical industry for its hepatoprotective properties, making it a key component in treatments for liver diseases such as hepatitis, cirrhosis, and alcohol-induced liver damage. It is often included in supplements and medications aimed at detoxifying and supporting liver function. Additionally, silibinin has shown potential in cancer therapy due to its ability to inhibit the growth of certain cancer cells and enhance the effectiveness of chemotherapy drugs. Its antioxidant properties also make it beneficial in reducing oxidative stress and inflammation, contributing to its use in managing conditions like diabetes and cardiovascular diseases. Furthermore, silibinin is being explored for its neuroprotective effects, particularly in addressing neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. Its versatility and therapeutic benefits continue to drive research and application across various medical fields.